Product Images Fluocinonide

This is a table showing the most common adverse reactions observed in adult clinical trials of Fluocinonide (in cream form, using both once or twice daily) compared to a vehicle cream. Adverse reactions had an occurrence of 1% or more. The table displays the number of patients who experienced each adverse reaction out of 216, 227, and 211 patients respectively. The table shows that headache, site irritation, nasopharyngitis, and nasal congestion are some of the most common adverse reactions. The statement suggests that the safety in patients aged 12 to 17 was similar to that observed in adults.*

The table provides information on the effectiveness of fluocinonide in treating plaque-type psoriasis in adults. The table compares the results of treatment once daily versus twice daily in a group of 107 subjects. The "F'Ugfg;‘r’g‘de Vehicle, oot Vehicle" text is not available for interpretation.*

This table presents the results of a study on the treatment of Atopic Dermatitis in adults. Different treatments were applied using Flugrcejr and Flugfér medications administered once or twice daily, and a placebo. The number of subjects achieving successful treatment or being cleared of the condition is presented, indicating the effectiveness of the different treatments.*

This is a statement indicating that a certain product or item is distributed by Perrigo®, a company located in Allegan, Michigan. The website of Perrigo® is also mentioned as www.perrigo.com.*

This product is distributed by Perrigo from Allegan, MI with the website www.perrigo.com.*